ATC code A05
| ATC codes | |||
|---|---|---|---|
| A Alimentary tract and metabolism | |||
| A01 Stomatological preparations | |||
| A02 Drugs for acid related disorders | |||
| A03 Drugs for functional gastrointestinal disorders | |||
| A04 Antiemetics and antinauseants | |||
| A05 Bile and liver therapy | |||
| A06 Drugs for constipation | |||
| A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents | |||
| A08 Antiobesity preparations, excluding diet products | |||
| A09 Digestives, including enzymes | |||
| A10 Drugs used in diabetes | |||
| A11 Vitamins | |||
| A12 Mineral supplements | |||
| A13 Tonics | |||
| A14 Anabolic agents for systemic use | |||
| A15 Appetite stimulants | |||
| A16 Other alimentary tract and metabolism products | |||
|
| |||
ATC code A05 Bile and liver therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup A05 is part of the anatomical group A Alimentary tract and metabolism.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QA05...[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A05A Bile therapy
A05AA Bile acid preparations
- A05AA01 Chenodeoxycholic acid
- A05AA02 Ursodeoxycholic acid
- A05AA03 Cholic acid
- A05AA04 Obeticholic acid
A05AB Preparations for biliary tract therapy
- A05AB01 Nicotinyl methylamide
A05AX Other drugs for bile therapy
- A05AX01 Piprozolin
- A05AX02 Hymecromone
- A05AX03 Cyclobutyrol
- QA05AX90 Menbutone
A05B Liver therapy, lipotropics
A05BA Liver therapy
- A05BA01 Arginine glutamate
- A05BA03 Silymarin
- A05BA04 Citiolone
- A05BA05 Epomediol
- A05BA06 Ornithine oxoglutarate
- A05BA07 Tidiacic arginine
- A05BA08 Glycyrrhizic acid (glycyrrhizin)
- QA05BA90 Methionine
A05C Drugs for bile therapy and lipotropics in combination
- Empty group
References
- ↑ "ATC/DDD Index 2016: code A05". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2016: code QA05". WHO Collaborating Centre for Drug Statistics Methodology.
| ||||||||||
This article is issued from Wikipedia - version of the Monday, January 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.